Epigral consolidated net profit rises 111.15% in the December 2024 quarter
Sales rise 36.84% to Rs 645.24 crore
Net profit of Epigral rose 111.15% to Rs 103.63 crore in the quarter ended December 2024 as against Rs 49.08 crore during the previous quarter ended December 2023. Sales rose 36.84% to Rs 645.24 crore in the quarter ended December 2024 as against Rs 471.52 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales645.24471.52 37 OPM %28.2925.99 -PBDT186.53104.81 78 PBT153.6273.93 108 NP103.6349.08 111Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 27 2025 | 4:58 PM IST